1. |
Nordmanna AJ, Kasendaa B, Briel M. Meta-analyses:what they can and cannot do. Swiss Med Wkly, 2012, 142:w13518.
|
2. |
Jansen JP, Naci H. Is network meta-analysis as valid as standard pair wise meta-analysis? It all depends on the distribution of effect modifiers. BMC Medicine, 2013, 11(7):159-166.
|
3. |
Jansen JP, Fleurence R, Devine B, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making:report of the ISPORT ask force on indirect treatment comparisons good research practices:Part 1. Value in Health, 2011, 14(4):417-428.
|
4. |
Senn S, Gavini F, Magrez D, et al. Issues in performing a network meta-analysis. Statistical Methods in Medical Research, 2013, 22(2):169-189.
|
5. |
TJ, Puhan MA, Vedula SS, et al. Network meta-analysis-highly attractive but more methodological research is needed. BMC Medicine, 2011, 9(1):79-83.
|
6. |
Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess, 2005, 9(26):1-134.
|
7. |
Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions:survey of published systematic reviews. BMJ, 2009, 338:b1147.
|
8. |
张天嵩, 熊茜.网络Meta分析在R软件中的实现.循证医学, 2012, 12(3):185-188.
|
9. |
曾宪涛, 曹世义, 孙凤, 等. Meta分析系列之六:间接比较及网状Meta分析.中国循证心血管医学杂志, 2012, 4(5):399-402.
|
10. |
张天嵩, 钟文昭.实用循证医学方法学.湖南:中南大学出版社. 2012:253-257.
|
11. |
曾宪涛.应用STATA做Meta分析.北京:军事医学科学出版社, 2014:150-176.
|
12. |
李幼平.循证医学.北京:人民卫生出版社. 2014:278-330.
|
13. |
田金徽, 李伦, 赵晔, 等.网状Meta分析的撰写与报告.中国药物评价, 2013, 30(6):321-323, 333.
|
14. |
曾宪涛, 张超, 杜亮.应用ADDIS软件实现网状Meta分析.中国循证医学杂志, 2013, 13(12):1508-1515.
|
15. |
张超, 徐畅, 曾宪涛.网状Meta分析中网状关系图的绘制.中国循证医学杂志, 2013, 13(11):1382-1386.
|
16. |
曾宪涛, 张超, 郭毅. R软件R2WinBUGS程序包在网状Meta分析中的应用.中国循证医学杂志, 2013, 13(9):1137-1144.
|
17. |
Fleurence RL, Naci H, Jansen JP. The critical role of observational evidence in comparative effectiveness research. Health Aff (Millwood), 2010, 29(10):1826-1833.
|
18. |
Jansen JP, Bergman GJD, Huels J, et al. The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-non-hip fractures in osteoporosis:a network meta-analysis. Semin Arthritis Rheum, 2011, 40(4):275-284.
|
19. |
Sutton A, Ades AE, Cooper N, et al. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoecnomics, 2008, 26(9):753-767.
|
20. |
Biondi-Zoccai GG, Agostoni P, Abbate A, et al. Adjusted indirect comparison of intracoronary drug-eluting stents:evidence from a metaanalysis of randomized bare-metal-stent-controlled trials. Int J Cardiol, 2005, 100(1):119-123.
|
21. |
Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants:a multipletreatments meta-analysis. Lancet, 2009, 373(9665):746-758.
|
22. |
Jansen JP, Crawford B, Bergman G, et al. Bayesian meta-analysis of multiple treatment comparisons:an introduction to mixed treatment comparisons. Value Health, 2008, 11(5):956-964.
|
23. |
Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments:combining direct and indirect evidence. BMJ, 2005, 331(7521):897-900.
|
24. |
Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med, 2004, 23(20):3105-3124.
|
25. |
Spiegelhalter D, Thomas A, Best N, et al. WinBUGS User Manual:Version 1.4. MRC Biostatistics Unit:Cambridge, 2003.
|